Ignite Creation Date:
2024-05-06 @ 3:28 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04647773
Status:
UNKNOWN
Last Update Posted:
2020-12-01
First Post:
2020-11-16
Brief Title:
To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain
Sponsor:
Haisco Pharmaceutical Group Co Ltd
Organization:
Haisco Pharmaceutical Group Co Ltd
Study Overview
Official Title:
A Multicenter Randomized Double-Blind Double-Dummy Placebo- and Pregabalin Capsule-Controlled 13-Week Adaptive-design Phase 23 Study to Evaluate the Efficacy and Safety of HSK16149 Capsules in Chinese Patients With Diabetic Peripheral Neuropathic Pain
Status:
UNKNOWN
Status Verified Date:
2020-11
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Investigate the efficacy and safety of HSK16149 capsules in Chinese diabetic peripheral neuropathic pain DPNP following 13 weeks treatment in comparison to placebo
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None